Combination cannabinoid-phenylethanoid formulation for treatment of inflammation and methods related thereto
AssigneeCanole LLC
InventorsDavid Bradley Schmidt, Alana L. Gray, David T. Coleman
Life of this patent
Estimating the term…
Abstract
The present invention describes cannabinoid formulations that combine cannabinoids, such as CBD, with other active agents within the phenylethanoid class of compounds, such as oleocanthal, which, in combination, provide synergistic anti-inflammatory effects. These combination preparations are capable of increasing anti-inflammatory effects when compared to each individual compound alone, and are further capable of delivery through a variety of administration routes.
Claims18
A composition for treatment of inflammatory conditions in an animal, said composition comprising:
- at least one cannabinoid;
- and
- at least one phenylethanoid;
- wherein said composition is capable of having an anti-inflammatory effect when administered to an animal, and
- wherein the at least one phenylethanoid comprises oleocanthal.
A method for preparing a combination formulation having anti-inflammatory properties, the method comprising the steps of:
- providing at least one cannabinoid;
- providing at least one phenylethanoid, wherein the at least one phenylethanoid comprises oleocanthal;
- and
- combining the at least one cannabinoid and the at least one phenylethanoid to form a combination formulation;
- wherein said combination formulation is capable of reducing inflammation in an animal administered said combination formulation.
Dependencies are inferred from the claim text.